<bill session="112" type="hr" number="279" updated="2013-07-20T01:05:24-04:00">
  <state datetime="2011-05-25">REFERRED</state>
  <status>
    <introduced datetime="2011-05-25"/>
  </status>
  <introduced datetime="2011-05-25"/>
  <titles>
    <title as="introduced" type="official">Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.</title>
  </titles>
  <sponsor id="400442"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2011-05-25">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2011-06-03">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Health promotion and preventive care"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary>5/25/2011--Introduced.
Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications. Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.</summary>
</bill>
